India wants Pfizer to do local study for approval
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 26, 2022
THURSDAY, MAY 26, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
India wants Pfizer to do local study for approval

Coronavirus chronicle

Reuters
13 January, 2021, 07:30 pm
Last modified: 13 January, 2021, 07:32 pm

Related News

  • India restricts sugar exports at 10 million tonnes
  • Worry as India to limit sugar export
  • Tata Steel says India export tax could alter output targets
  • India’s billionaire race sees one tycoon pulling away
  • India says 'substantive outcomes' from Biden, Modi talks

India wants Pfizer to do local study for approval

Russia's Sputnik V, a shot undergoing last-stage trials in India, will soon apply for emergency-use approval in the country

Reuters
13 January, 2021, 07:30 pm
Last modified: 13 January, 2021, 07:32 pm
FILE PHOTO: A sign is pictured outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020. REUTERS/Carlo Allegri/File Photo
FILE PHOTO: A sign is pictured outside Pfizer Headquarters in the Manhattan borough of New York City, New York, U.S., July 22, 2020. REUTERS/Carlo Allegri/File Photo

Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.

Serum Institute of India, the local manufacturer of the vaccine developed by AstraZeneca Plc and Oxford University, has done a similar study on more than 1,500 people over months before seeking and receiving emergency approval in the country.

Local media have reported that Pfizer had sought an exception when last month it became the first company to seek emergency-use approval in India for its vaccine already in use overseas. The company has not attended subsequent meetings called by India's drugs regulator.

"As of now, the pre-condition for any vaccine to be implemented in India is that you have to do a bridging trial," Vinod K. Paul, who heads a government panel on vaccine strategy, said in an interview in his office near the parliament building.

A Pfizer spokeswomen did not immediately respond to a request seeking comment.

Paul also said Russia's Sputnik V, a shot undergoing last-stage trials in India, will soon apply for emergency-use approval in the country.

No vaccine maker will be given indemnity by the government should something go wrong, Paul said. Serum Institute had written to the government seeking indemnity. AstraZeneca has said it has received such indemnity in many other countries.

India has also approved for emergency use a vaccine developed locally by Bharat Biotech.

Top News

India / Pfizer Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Wheat stock at 3-year low and that may not be good for rice
    Wheat stock at 3-year low and that may not be good for rice
  • Photo: Collected
    Bangladesh among top 20 prospective solar farm capacity nations
  • Bangladesh Bank to sit with ABB, BAFEDA Thursday
    Bangladesh Bank to sit with ABB, BAFEDA Thursday

MOST VIEWED

  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules
  • A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
    Pfizer says 3 Covid shots protect children under 5
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing urges millions to keep working from home amid Covid outbreak menace
  • Picture: PTI
    Saudi Arabia bans travel to India, 15 other countries over Covid outbreaks
  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert

Related News

  • India restricts sugar exports at 10 million tonnes
  • Worry as India to limit sugar export
  • Tata Steel says India export tax could alter output targets
  • India’s billionaire race sees one tycoon pulling away
  • India says 'substantive outcomes' from Biden, Modi talks

Features

Psycure has received various awards for their extraordinary contributions to promoting Sustainable Development Goals. Photo: Courtesy

Psycure: Meet the organisation serving the underserved university students (and beyond) with mental healthcare 

20h | Panorama
Underlying problems such as school dropouts need to be addressed first before taking a legal route to stop child labour. Photo: Reuters

‘Child labour in a country like Bangladesh is primarily a development issue, not so much of enforcement’

22h | Panorama
The balcony railings of the Boro Sardar Bari in Sonargaon. Made of cast iron, these railings feature vertical posts with intricate designs on top. Photo: Noor-A-Alam

The evolution of railing and grille designs

1d | Habitat
A Russian army service member fires a howitzer during drills at the Kuzminsky range in the southern Rostov region, Russia January 26, 2022. REUTERS/Sergey Pivovarov/File Photo

3 months of Ukraine war : Miscalculations, resistance and redirected focus

1d | Analysis

More Videos from TBS

Where the people have more weapons than military

Where the people have more weapons than military

9h | Videos
Govt plans to amnesty in the offing to bring back laundered money to meet dollar crises

Govt plans to amnesty in the offing to bring back laundered money to meet dollar crises

12h | Videos
Poet Nazrul Islam’s 123rd birth anniversary observed

Poet Nazrul Islam’s 123rd birth anniversary observed

12h | Videos
Soaring commodity prices put pressure on budget

Soaring commodity prices put pressure on budget

16h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

3
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

4
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

5
Illustration: TBS
Banking

Let taka slide

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab